Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Equity Placing

9 Sep 2008 14:19

RNS Number : 0555D
Ovoca Gold PLC
09 September 2008
 



Ovoca Gold PLC ("Ovoca" or the "Company")

Equity Placing

Ovoca (London AIM (OVG.L), Frankfurt (OVX.GR) and Dublin IEX (OVX.IR) is pleased to announce that it has agreed the terms of a conditional placing of 6,471,000 new ordinary shares of €0.025 each ("Ordinary Share") at a price of £0.065 per Ordinary Share (the 'Placing Shares'), raising gross proceeds of £420,615 ("the Placing"). 

The Placing price is 10.9premium to the average mid market closing price on the London Stock Exchange of £0.059 per Ordinary share on the ten trading days prior to 9 September 2008 In addition, the Company has issued warrants to subscribe for 3,235,500 Ordinary Shares which have an exercise price of £0.082 per share and can be exercised at any time up to 4 September 2009 The warrants, which are transferable, will not be quoted on any market. The Placing is conditional on the Placing Shares being admitted to trading on the IEX Market of the Irish Stock Exchange ("IEX") and the AIM Market of the London Stock Exchange ("AIM").

The net proceeds of the Placing will be used in the evaluation and development of the Goltsovoye silver deposit, located in the Magadan Oblast of north-east Russia, and for working capital purposes. 

Leonid Skoptsov, CEO of Ovoca, will subscribe for the following Placing Shares:

 
 
Placing Shares subscribed for:
Resultant holding of Ordinary Shares:
% of Enlarged Share Capital:
Subishico Trading Company Ltd*
2,157,000
39,578,743
8.9536
 
 
 
 
 
 
 
 
Warrants received pursuant to the Placing:
Resultant holding of Warrants:
Subishico Trading Company Ltd*
 
1,078,500
4,943,225
 
 
 
 
 

* The Saint George Trust, of which Leonid Pavlovich Skoptsov is a director and beneficial owner of, is a beneficial shareholder in Subishico Trading Co Ltd.

Application will be made to the Irish Stock Exchange and the London Stock Exchange for the placing shares to be admitted to trading on IEX and AIM respectively Admission is expected to occur by 16 September 2008.

For further information please visit www.ovocagold.comwww.ovocagold.eu  or contact:

Leonid Skoptsov - Ovoca Gold Plc

Tel + 7 (0)495 648 2646

Email: leonid.skoptsov@ovocagold.com

Danesh Varma - Ovoca Gold Plc

Tel: 08452 606 034 Fax: 020 7653 9889 Email: danesh.varma@ovocagold.com

John Frain - Davy

Tel : +353 (0)1 679 6363 

This announcement has been issued through the Companies Announcement Service of

The Irish Stock Exchange.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEUUUBUBUPRGWB
Date   Source Headline
5th Feb 20267:00 amRNSChange of Name
28th Jan 20268:00 amRNSReadmission - Ovoca Bio PLC
28th Jan 20267:00 amRNSFirst Day of Dealings on AIM
27th Jan 20262:32 pmRNSResult of Meeting
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20257:00 amRNSNotice of AGM
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSNotice of AGM
13th Nov 20257:00 amRNSChange of Broker
30th Sep 20251:09 pmRNSReplacement Half Year Report
30th Sep 20257:00 amRNSHalf-year Report
26th Jun 20257:00 amRNSPublication of 2024 Annual Report
5th Jun 20257:00 amRNSDelisting from Euronext Growth Exchange
7th May 20257:30 amRNSSuspension - Ovoca Bio plc
7th May 20257:00 amRNSProposed Acquisition, Disposal & Reverse Takeover
3rd Mar 20252:00 pmRNSManagement Changes
18th Dec 20246:00 pmRNSResult of AGM
18th Nov 20247:00 amRNSNotice of AGM
11th Oct 20245:30 pmRNSHolding(s) in Company
9th Oct 20245:45 pmRNSSale of Treasury Shares
25th Sep 20247:00 amRNSHalf-year Report
2nd Sep 20242:30 pmRNSConsultancy Agreement
15th Jul 20247:00 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSDirectorate Change
28th Jun 20247:00 amRNSAnnual Financial Report
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.